Combination Therapy Stops Loss of Kidney Function in Rare Genetic Disease

Armen Hareyan's picture

Fabry Disease Treatment

A combination of two types of blood pressure-lowering drugs - an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.